Back

Meta-analysis on the effectiveness of SGLT2 inhibitors in heart failure

25 March 2023 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Antidiabetic Pharmacotherapy ACVC Premium Access ESC Acute CardioVascular Care 2023 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Miss Sarvinoz Albalushi

University of Debrecen, Debrecen (Hungary)

40 More presentations in this session

Presentation thumbnail
Protective role of chronic beta-blocker intake against the appearance of complex ventricular arrhythmias in acute coronary syndrome.
Doctor A. Gomez Gonzalez (Santa Cruz de Tenerife, ES)
Abstract Slides
Presentation thumbnail
Coronary microvascular disease is associated with arterial stiffness in patients with ischemia and no obstructive coronary arteries
Doctor A. Sakalidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Antiplatelet de-escalation switch in patients with acute coronary syndrome and percutaneous revascularisation in real life
Mr F. Escalona (Seville, ES)
Abstract Slides
Presentation thumbnail
Stent restenosis: identifying predictors
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides
Presentation thumbnail
A prediction model for ventricular arrythmias in the acute phase of infarction
Miss M. Rivadeneira Ruiz (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

ESC Acute CardioVascular Care 2023

25 March 2023 08:30 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis
7 April 2022
thumbnail
Congress Presentation
Impact of sodium-glucose co-transporter inhibitors in mortality and decongestion in cardiac amyloidosis: A systematic review and meta-analysis
1 September 2025
thumbnail
Webinar
Clinical trials and highlights from ACC 2024
10 April 2024
thumbnail
Congress Presentation
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources